Cargando…

Analysis of Givinostat/ITF2357 Treatment in a Rat Model of Neonatal Hypoxic-Ischemic Brain Damage

The histone deacetylase inhibitor (HDACi) Givinostat/ITF2357 provides neuroprotection in adult models of brain injury; however, its action after neonatal hypoxia-ischemia (HI) is still undefined. The aim of our study was to test the hypothesis that the mechanism of Givinostat is associated with the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pawelec, Paulina, Sypecka, Joanna, Zalewska, Teresa, Ziemka-Nalecz, Malgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368553/ https://www.ncbi.nlm.nih.gov/pubmed/35955430 http://dx.doi.org/10.3390/ijms23158287

Ejemplares similares

Oncogenic BRAF and p53 Interplay in Melanoma Cells and the Effects of the HDAC Inhibitor ITF2357 (Givinostat)
por: Celesia, Adriana, et al.
Publicado: (2023)

The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
por: Pawelec, Paulina, et al.
Publicado: (2020)

Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells
por: Angeletti, Francesca, et al.
Publicado: (2016)

Aberrant Complement System Activation in Neurological Disorders
por: Ziabska, Karolina, et al.
Publicado: (2021)

Effect of the HDAC Inhibitor, Sodium Butyrate, on Neurogenesis in a Rat Model of Neonatal Hypoxia–Ischemia: Potential Mechanism of Action
por: Jaworska, Joanna, et al.
Publicado: (2019)

The potential neuroprotective role of a histone deacetylase inhibitor, sodium butyrate, after neonatal hypoxia-ischemia
por: Jaworska, Joanna, et al.
Publicado: (2017)

The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to Apoptosis
por: Celesia, Adriana, et al.
Publicado: (2022)

Impact of a Histone Deacetylase Inhibitor—Trichostatin A on Neurogenesis after Hypoxia-Ischemia in Immature Rats
por: Zalewska, Teresa, et al.
Publicado: (2020)

Sodium Butyrate, a Histone Deacetylase Inhibitor, Exhibits Neuroprotective/Neurogenic Effects in a Rat Model of Neonatal Hypoxia-Ischemia
por: Ziemka-Nalecz, Malgorzata, et al.
Publicado: (2016)

Impact of neonatal hypoxia‐ischaemia on oligodendrocyte survival, maturation and myelinating potential
por: Ziemka‐Nalecz, Malgorzata, et al.
Publicado: (2017)

Neonatal Rat Glia Cultured in Physiological Normoxia for Modeling Neuropathological Conditions In Vitro
por: Gargas, Justyna, et al.
Publicado: (2022)

Sexual Dimorphism in Neurodegenerative Diseases and in Brain Ischemia
por: Zalewska, Teresa, et al.
Publicado: (2022)

Sex Differences in Brain Disorders
por: Ziemka-Nalecz, Malgorzata, et al.
Publicado: (2023)

Oligodendrocyte Response to Pathophysiological Conditions Triggered by Episode of Perinatal Hypoxia-Ischemia: Role of IGF-1 Secretion by Glial Cells
por: Janowska, Justyna, et al.
Publicado: (2020)

The Differentiation of Rat Oligodendroglial Cells Is Highly Influenced by the Oxygen Tension: In Vitro Model Mimicking Physiologically Normoxic Conditions
por: Janowska, Justyna, et al.
Publicado: (2018)

Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma
por: Di Martile, Marta, et al.
Publicado: (2018)

The Potential Role of Metalloproteinases in Neurogenesis in the Gerbil Hippocampus Following Global Forebrain Ischemia
por: Wójcik-Stanaszek, Luiza, et al.
Publicado: (2011)

ITF2357 transactivates Id3 and regulate TGFβ/BMP7 signaling pathways to attenuate corneal fibrosis
por: Lim, Rayne R., et al.
Publicado: (2016)

Control of cytokine mRNA degradation by the histone deacetylase inhibitor ITF2357 in rheumatoid arthritis fibroblast-like synoviocytes: beyond transcriptional regulation
por: Angiolilli, Chiara, et al.
Publicado: (2018)

Long non-coding RNA H19 enhances the pro-apoptotic activity of ITF2357 (a histone deacetylase inhibitor) in colorectal cancer cells
por: Zichittella, Chiara, et al.
Publicado: (2023)

Resatorvid protects against hypoxic-ischemic brain damage in neonatal rats
por: Jiang, Li-Jun, et al.
Publicado: (2020)

HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism
por: Cui, Jian, et al.
Publicado: (2023)

CompTIA IT Fundamentals (ITF+) Study Guide
por: Docter, Quentin
Publicado: (2018)

Estrogen inhibits lipid peroxidation after hypoxic-ischemic brain damage in neonatal rats★
por: Zhu, Hui, et al.
Publicado: (2012)

Circular RNA expression profiles in neonatal rats following hypoxic-ischemic brain damage
por: Jiang, Li, et al.
Publicado: (2019)

Dihydroartemisinin attenuates hypoxic-ischemic brain damage in neonatal rats by inhibiting oxidative stress
por: Xiong, Qian, et al.
Publicado: (2022)

On the possibility of inserting an accelerating cavity after the stripper in the ITF
por: Lombardi, Alessandra
Publicado: (1995)

Neuroprotection of lamotrigine on hypoxic-ischemic brain damage in neonatal rats: Relations to administration time and doses
por: Yi, Yong-Hong, et al.
Publicado: (2008)

Telomerase reverse transcriptase promotes angiogenesis in neonatal rats after hypoxic-ischemic brain damage
por: Li, Jiao, et al.
Publicado: (2022)

Irradiation Measurements of the Hitachi H8S/2357 MCU
por: Navarrete, J J, et al.
Publicado: (2003)

Peptidome analysis of cerebrospinal fluid in neonates with hypoxic-ischemic brain damage
por: Hou, Xuewen, et al.
Publicado: (2020)

Neuroprotective Mechanism of Icariin on Hypoxic Ischemic Brain Damage in Neonatal Mice
por: Wang, Mengxia, et al.
Publicado: (2022)

Hypothermia Modulates Cytokine Responses After Neonatal Rat Hypoxic-Ischemic Injury and Reduces Brain Damage
por: Yuan, Xiangpeng, et al.
Publicado: (2014)

N-Acetylaspartylglutamate (NAAG) Pretreatment Reduces Hypoxic-Ischemic Brain Damage and Oxidative Stress in Neonatal Rats
por: Bratek, Ewelina, et al.
Publicado: (2020)

Proteomic analysis of the effects of caffeine in a neonatal rat model of hypoxic‐ischemic white matter damage
por: Yang, Liu, et al.
Publicado: (2022)

Myricetin attenuates hypoxic-ischemic brain damage in neonatal rats via NRF2 signaling pathway
por: Chen, Tingting, et al.
Publicado: (2023)

Ceftriaxone attenuates hypoxic-ischemic brain injury in neonatal rats
por: Lai, Pei Chun, et al.
Publicado: (2011)

A new Hypoxic Ischemic Encephalopathy model in neonatal rats
por: Lyu, Hao, et al.
Publicado: (2021)

Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation
por: Milan, Marika, et al.
Publicado: (2018)

Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat Combination
por: Hoch, Lucile, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5eaee4rign46chn6qsc0sja16p